|
NUB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.852000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.267600E-01 |
| Normal-vs-Stage2 |
2.313800E-01 |
| Normal-vs-Stage3 |
6.287800E-01 |
| Normal-vs-Stage4 |
2.975200E-01 |
| Stage1-vs-Stage2 |
2.540400E-02 |
| Stage1-vs-Stage3 |
3.888000E-01 |
| Stage1-vs-Stage4 |
9.697200E-01 |
| Stage2-vs-Stage3 |
1.269050E-01 |
| Stage2-vs-Stage4 |
5.974000E-02 |
| Stage3-vs-Stage4 |
5.529400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.848950E-01 |
| Normal-vs-AfricanAmerican |
2.210400E-01 |
| Normal-vs-Asian |
6.357600E-02 |
| Caucasian-vs-AfricanAmerican |
7.185600E-01 |
| Caucasian-vs-Asian |
2.601400E-01 |
| AfricanAmerican-vs-Asian |
6.638000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.424800E-01 |
| Normal-vs-Female |
1.524400E-01 |
| Male-vs-Female |
1.390370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.610200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.220000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.777400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.038400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.072000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.383000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.830400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.473900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.855000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.856600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.400000E-01 |
| Classical-VS-Follicular |
9.28629995122776E-09 |
| Classical-VS-Other |
1.159450E-01 |
| Classical-VS-Normal |
4.019400E-03 |
| Tall-VS-Follicular |
2.786500E-04 |
| Tall-VS-Other |
3.827400E-01 |
| Tall-VS-Normal |
1.999580E-01 |
| Follicular-VS-Other |
5.518200E-01 |
| Follicular-VS-Normal |
1.616340E-03 |
| Other-VS-Normal |
6.308200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.542200E-01 |
| Normal-vs-N1 |
7.210800E-01 |
| N0-vs-N1 |
8.020400E-01 |
|
|
